Liver Disease Clinical Trials

Showing 41-60 of 690 trials

Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation

NCT06169592

The aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.

Liver CirrhosisLiver Transplant; Complications

Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov30 participantsStarted Apr 2022

Tashkent, Uzbekistan

ACTIVE_NOT_RECRUITINGPHASE3

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

NCT03301506

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Primary Biliary Cirrhosis

Gilead Sciences500 participantsStarted Dec 2017

Little Rock, Arkansas, United States • Palo Alto, California, United States • Pasadena, California, United States +105 more locations

Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

Related Searches

Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation

Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation

Growth Hormone in Decompensated Liver Cirrhosis

Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound Devices

A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease

Is There an Association Between Quadriceps Strength and Different Markers of Fragility in Patients With Cirrhosis?

Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease

Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Gastrointestinal Bleeding and Acute Kidney Injury

Molecular Mechanism of Exercise in Cirrhosis

Timing of Endoscopic Intervention for Acute Variceal Hemorrhage: an RCT

A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes

Erlotinib for Hepatocellular Carcinoma Chemoprevention

Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)

Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial

Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidney or Spleen Biopsy Procedures.

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH